More than 48 million people in the U.S. meet the criteria for a substance use disorder. 86% of them have not received treatment.* The urgent need for new, effective therapies has never been greater, but substance use disorder clinical trials come with distinct challenges, from high dropout rates and comorbid conditions to adherence and real-world applicability.
When you need a substance use disorder CRO who understands the complexities and urgency of substance use disorder research, your pathway to informed protocols, specialized patient populations, and end-to-end clinical trial excellence starts with Clinilabs.
The Substance Use Disorder CRO to Advance Your Trial
Our exclusive CNS focus gives your substance use disorder (SUD) trials powerful advantages.
With deep experience across psychiatry, neurology, and addiction medicine, we understand the biological, behavioral, and regulatory complexities that define SUD research. Our specialized network, precision-driven protocols, and integrated data systems ensure every trial is set up for real-world impact and regulatory success, while our dedicated team works in concert to bring your product to the people who need it as quickly as possible.
Your Full-Service Substance Use Disorder CRO
We offer solutions spanning study design, site selection, patient recruitment, data management, and regulatory support — all tailored to the unique demands of SUD research.
*Substance Abuse and Mental Health Services Administration (SAMHSA). 2023 National Survey on Drug Use and Health (NSDUH). https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases/2023
